Method for sterilization of biological preparations

a technology for biological preparations and preparations, applied in the field of sterilization of biological preparations, can solve the problems of wbc in a transfusion liquid, damage to biological materials during preservation, and damage to recipients, and achieve the effect of reducing the amount or activity

Inactive Publication Date: 2010-08-05
CORE DYNAMICS
View PDF58 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When storing cells, tissue or other biological material, there is always the danger of contamination from bacteria, viruses, yeasts, molds, fungi etc., and sometimes the contaminants are present in the biological material when it is first collected.
Contaminants are such agents that may damage the biological material during preservation and / or harm the recipient when the product is used (e.g. transfused, injected or eaten).
The presence of WBC in a transfusion liquid is a problem due to graft vs. host disease, in which the transfused WBC (mainly the lymphocytes) attack the recipient's body.
However, these processes may damage biological material (e.g. when it is sensitive to heat) or prove to be inefficient (e.g. when the biological material is filtered with some contaminants).
1998) but it was concluded that exposure to gamma radiation at levels up to 7.5 mega Rad was ineffective at sterilizing the sample.
Furthermore, gamma radiation can be damaging to radiation-sensitive products.
However, as UV radiation is absorbed by water, it is practically ineffective for removal of contaminants that are in a water-containing sample (liquid or ice).
However, sterilization of biological material in WO 2004 / 0091938 was restricted to wet biological material or to non-cellular portions of a blood preparation (i.e. not including RBC or platelets), apparently since “sensitive biologicals, such as blood, would lose viability and activity if subjected to freezing for irradiation purposes and then thawing prior to administration to a patient” (id.).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for sterilization of biological preparations

Examples

Experimental program
Comparison scheme
Effect test

example 1

The Effect of UV Exposure on the Survival of Lyophilized RBC

[0030]The effects of irradiation and freeze drying on red blood cells (RBC) were evaluated in this experiment. The freezing solution used was composed of 30% (w / v) dextran in PBS (Ca2+ and Mg2+ free). Packed RBC obtained from the Israeli Blood Services were mixed at a ratio of 1:1 (v / v) with the freezing solution. 2.5 ml of RBC solution was put in a 16 mm diameter of glass test tubes (Manara, Israel) which were then frozen. Freezing was done using the MTG freezing device (IMT, Israel) at a cooling rate of 1000° C. / min; (thermal gradient) G=5.5° C. / mm, V=3 mm / sec. The samples were also rotated at 56 RPM (rounds per minute).

[0031]After freezing, samples were put in a lyophilizer (Labconco, USA) for 3 days (condenser −80° C.). After 3 days of lyophilization, when the samples contained 10% or less of their original water content, one sample was placed in a Petri dish and exposed to UV radiation for 1 hour and the other was prot...

example 2

The Effect of UV Radiation on Lyophilized RBC Survival

[0033]In this experiment packed RBC were frozen with a freezing solution containing: 30% (w / v) dextran 40,000 Dalton and 0.47 mg / ml EGCG (Cayman Chemical, USA). The freezing solution and the packed RBC were mixed in a ratio of 1:1 (v / v). 2.5 ml of the cell suspension were put in 16 mm diameter glass test tubes (Manara, Israel). A total of 4 test tubes were frozen. The samples were frozen at a cooling rate of 1000° C. / min; (thermal gradient) G=5.5° C. / mm, V=3 mm / sec using the MTG Device (IMT, Israel). The samples were also rotated at 56 RPM.

[0034]After freezing, samples were placed in liquid nitrogen. After the passage of varying time periods (between ½ hour to a few weeks) samples were placed in a lyophilizer (Labconco, USA) with a condenser temp of −80° C.) for 72 hours, and the samples were dried such that they had the appearance of a powder and had less than 10% of their original water content. Then samples were transferred to...

example 3

The Effect of Partial Drying on RBC Survival

[0036]Fresh whole rat's blood (extracted from Sprague-Dawley rats) was washed once. Plasma was removed and the packed RBCs were suspended in a 1:3 ratio (v / v) with a freezing solution composed of 0.945 mg / ml EGCG and 20% (w / v) Dextran 40 kD in 0.9% (w / v) NaCl solution, and the final hematocrit was 25%. Three samples (2.5 ml each) were frozen each in a 16 mm diameter glass test tube (Manara, Israel) using the MTG device (IMT, Israel), with the following parameters: velocity=3 mm / sec; temperature gradient was 5.5° C. / mm, the test tubes were rotated at 60 rpm. After freezing, samples were stored in LN until lyophilization. Lyophilization was done in a special lyophilization device (IMT, Israel) subject of co-pending PCT application No. IL2005 / 000124, which has a condenser temperature of −190° C. and samples were kept at a temperature of −20° C. Samples remained in the device for 48 hours. After 48 hours samples were taken out and thawed in a ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
diameteraaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

Provided is a method for the sterilization of a biological preparation including desired viable biological entities. The method includes irradiating a dried (e.g. freeze-dried) biological preparation with UV radiation at an intensity and for a duration sufficient to reduce the amount or activity of living-matter contaminants in the biological preparation, the intensity and duration selected such that at least part of the desired biological entities in the sample remains viable. The described method is particularly suitable for the reduction of the amount or activity of contaminants such as bacteria or viruses from biological preparations including red blood cells or platelets.

Description

FIELD OF THE INVENTION[0001]The invention relates to the sterilization of biological preparations. More specifically the present invention relates to a method for the sterilization of biological preparations and to sterilized biological preparations.LIST OF REFERENCES[0002]The following references are considered to be pertinent for the purpose of understanding the background of the present invention:[0003]1. US 2004 / 067157 Methods for Sterilizing Biological Materials;[0004]2. WO 2004 / 009138 Methods for Sterilizing Milk;[0005]3. PCT IL2005 / 000125 Biological Material and Methods and Solutions for Preservation Thereof;[0006]4. U.S. Pat. No. 5,709,992 Method for disinfecting red blood cells;[0007]5. U.S. Pat. No. 6,482,585 Storage and maintenance of blood products including red blood cells and platelets;[0008]6. Hustom, et al. Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth. Am J Clin Pathol. 1998; 109(6):743-7[0009]7. Smith, et ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/078A61L2/10A61L2/00A61M1/16C12N5/07
CPCA61L2/0047A61L2/0035
Inventor NATAN, YEHUDITKANIAS, TAMIR
Owner CORE DYNAMICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap